Please enable Javascript
Othman Al-Sawaf, MD
Articles by Othman Al-Sawaf, MD
What Is the Best Strategy for Frontline Venetoclax Plus Obinutuzumab in CLL?
Othman Al-Sawaf, MD
Chronic Lymphocytic Leukemia
|
September 24, 2023
Othman Al-Sawaf, MD, and Nicole Lamanna, MD, debate approaches in this Point | Counterpoint.
View More